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Best practices in laboratory culture management often include cryopreservation of microbiota, but this can be challenging with some virus particles. By preserving viral isolates
researchers can mitigate genetic drift and laboratory-induced selection, thereby maintaining
genetically consistent strains between experiments. To this end, we developed a method to
cryopreserve the model, green-alga infecting virus, Paramecium bursaria Chlorella virus 1
(PBCV-1). We explored cryotolerance of the infectivity of this virus particle, whereby freezing without cryoprotectants was found to maintain the highest infectivity (~2.5%). We then
assessed the cryopreservation potential of PBCV-1 during an active infection cycle in its
Chlorella variabilis NC64A host, and found that virus survivorship was highest (69.5 ±
16.5%) when the infected host is cryopreserved during mid-late stages of infection (i.e.,
coinciding with virion assembly). The most optimal condition for cryopreservation was
observed at 240 minutes post-infection. Overall, utilizing the cell as a vehicle for viral cryopreservation resulted in 24.9–30.1 fold increases in PBCV-1 survival based on 95% confidence intervals of frozen virus particles and virus cryopreserved at 240 minutes postinfection. Given that cryoprotectants are often naturally produced by psychrophilic organisms, we suspect that cryopreservation of infected hosts may be a reliable mechanism for
virus persistence in non-growth permitting circumstances in the environment, such as
ancient permafrosts.

Data Availability Statement: All relevant data are
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Foundation (#4971) to SWW. Funding for open
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Introduction
Viruses are abundant components of all biological systems and they likely infect every lineage
of eukaryotic algae. Their impact is most readily noticed following infection and lysis of abundant bloom forming algae [1–3], though lytic activity of all algal viruses contributes to significant biomass recycling via the ‘viral shunt’ [4]. To date, 65 eukaryotic algal viruses have been
isolated and developed as laboratory strains [5, 6]. Most of these are maintained through serial
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propagation on their respective hosts. Though this has been effective for culturing many
strains over the last few decades [7, 8], each passage allows for genetic mutations that can accumulate in a population [9], leading to a deviation from a standard ‘wild-type.’ Moreover, it is
imperative to control evolution following the development of genetically tractable algal hosts
[10] and (ultimately) virus systems. Although seed-stock systems can be developed without
cryopreservation, many systems are not amenable to this either because the virus particles are
degraded during purification efforts or lose their infectivity during storage. Moreover, it can
take time to achieve axenic status with new virus isolates, thus making contaminating bacterial
activity a significant source of degradation. Thus, a protocol for successful virus cryobiological
preservation that is applicable to a wide variety of algae-virus systems would offer an opportunity to universally improve virus management and distribution in the laboratory.
Cryopreservation is not a new concept in biological sciences. For most protocols, it involves
controlled cooling of biota to sub-freezing temperatures to achieve biological cessation while
preserving viability. This most often manifests as slow-cooling at a rate of 1˚C / min in the
presence of osmoprotectant(s) (e.g., dimethylsulfoxide (DMSO), glycerol) for long-term storage at -130˚C or below [11]. Too slow a cooling rate can result in higher intracellular concentration of osmoprotectants, resulting in toxicity, whereas too fast a cooling rate allows the
formation of intracellular ice crystals which can rupture cell membranes [12]. The thawing
process is typically quick, as microbial death is commonly associated with slow thaw rates.
Though cryopreservation is a standard method for maintaining cellular organisms, it has
rarely been utilized for the preservation of algal viruses.
One eukaryotic algal virus cryopreservation protocol is in existence. It was developed for
HaV, a dsDNA virus that infects the red tide forming dinoflagellate Heterosigma akashiwo
[13]. Researchers investigated a combination of cryoprotectants and storage temperatures with
the highest recovery (8.3% of infectious virus) employing flash freezing of HaV particles suspended in 20% DMSO. This protocol has been adapted for a handful of other algal viruses
with viable recovery ranging from < 1% to 27% [14–16]. The typical low recovery in these procedures is likely due to physiological differences between viruses and cells including differences in permeability, osmolarity tolerance, and toxicity to osmoprotectants. It is also clear
that these protocols deviate from the standard method which controls the cooling rate; to our
knowledge this has not been tested as a matter of improving virus particle survival. Owing to
these complications, we decided to take a new approach by investigating cryopreservation
recovery and stability of actively infecting, cell-associated algal viruses.
Chloroviruses are large (> 300 kb) dsDNA viruses in the family Phycodnaviridae [17]. They
are members of the proposed order the Megavirales [18], also known as “giant” viruses, and
remain the best characterized algal-virus system to date. Isolated in the early 1980’s [7], the
prototype chlorovirus Paramecium bursaria Chlorella virus 1 (PBCV-1) has been maintained
through serial propagation on its host, Chlorella variabilis NC64A. PBCV-1 is inactivated by
freezing, though other closely related virus strains, including other chloroviruses, persist
through freeze/thaw events [19, 20]. As a great deal of research has centered on PBCV-1,
including genomics [21], transcriptomics [22, 23], and proteomics [21], it is important to
develop a successful cryopreservation protocol for this strain that may serve as a model for
preserving algal viruses. There are several reports of cryopreservation techniques for eukaryotic algae [24–28] which might be adapted for the preservation of actively replicating
chloroviruses.
Here, we tested the cryo-potential of chlorovirus PBCV-1 using a protocol that yielded consistent recovery (~50% viable cells) of four strains of algae over 15 years: Chlorella vulgaris C27, Chlorella vulgaris M-207A7, Nannochloropsis oculate ST-4, and Tetraselmis tetrathlele T501 [29]. Owing to the close relationship between C. vulgaris and C. variabilis, as well as the
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consistent results across unique algae, we elected to determine if these results could be recapitulated in PBCV-1. To test this, we attempted cryopreservation of both the virus particle as well
as the virus replicating in its host.

Materials and methods
Virus particle cryopreservation
Chlorella variabilis NC64A was infected with PBCV-1 during mid-logarithmic growth at standard culturing conditions (25˚C; continuous light exposure at 30μEin/m2/s) using Modified
Bold’s Basal Medium [30]. Following complete lysis, the viral lysate was pre-filtered through a
sterile, 0.45 μm polycarbonate syringe filter and titered by plaque assay [31, 32] for initial infectivity assessments. Cryoprotectant choice was guided by Nakanishi et al. [29], in which a combination of 5% DMSO (v/v), 5% ethylene glycol (v/v), and 5% proline (w/v) was found to
consistently produce the highest algal recoveries. Stock solutions of each cryoprotectant were
made at a concentration of 30% with sterilized Milli-Q water and combined in a 1:1:1 ratio to
yield a final concentration of 10% for each compound. For virus particle cryopreservation, 1
mL of PBCV-1 particles (7.82x 108 plaque forming units (PFUs) per ml) was added to 1 mL of
ice-chilled cryoprotectant solution contained in a 2-mL cryovial. The cryovials were incubated
on ice for 45 min, then transferred to a freeze-rate controlled container (Mr. Frosty, Thermo
Fisher Scientific Inc., USA) filled with isopropanol for overnight incubation at -80˚C. The next
morning, cryovials were transferred to a -150˚C freezer. At the designated recovery times, vials
were removed from the freezer and set in a 40˚C water bath. After thawing, the samples were
serially diluted ten-fold in 50 mM Tris-HCl (pH = 7.8) and virus infectivity was determined by
plaque assay [31]. Virus viability was calculated as a percentage by comparison to the initial
virus particle stock titer before cryopreservation. Long-term experiments assessed the stability
of virus infectivity in particles stored at -150˚C.

Infected Chlorella cryopreservation
Chlorovirus PBCV-1 was propagated as described above and titered to obtain infectious
PFUs/ml. This virus particle stock was used to infect late-logarithmically growing C. variabilis
NC64A at an M.O.I. of 5, at which point infected cultures were returned to standard incubation conditions. At 1, 10, 30, 60, 120, 180, 240, 300, and 360 min post-infection (PI), 1 mL
aliquots of infected cells were mixed with 1 mL of ice-chilled cryoprotectants [final concentration: 5% DMSO (v/v), 5% ethylene glycol (v/v), and 5% proline (w/v)] in duplicates. The mixture was incubated on ice for 45 min, then transferred to a freeze-rate controlled container
(Mr. Frosty, Thermo Fisher Scientific Inc., USA has a -1C/min cooling rate) filled with isopropanol for overnight incubation at -80˚C. The next morning, cryovials were immediately transferred to a -150˚C freezer. At the designated recovery times, vials were removed from the
freezer and placed in a 40˚C water bath. After thawing, the infected cells were pelleted in a Sorvall Legend RT Benchtop Centrifuge at 3,700 rpm (~3,000 rcf) for 10 min: (free virus requires
higher speeds for pelleting). Cell pellets were re-suspended in 2 mL of 0.01M HEPES solution
(pH = 6.5). Suspensions were immediately diluted and plaque assayed, plating late-infection
treatments first. Viability was determined as a percentage of the pre-frozen cellular concentration (3.57 x 106 cells/mL), as only surviving infected cells would be capable of producing plaques. Long-term experiments were conducted in the same manner, though only time points
10, 180, and 240 min PI were collected and assayed. The complete step-by-step method can be
found at protocols.io [33].
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Results
Following the cryopreservation procedures of other algal virus researchers [13–16], we investigated the cryo-potential of the PBCV-1 particle. Cryoprotectant alone treatments elicited a
lethal effect: ~87% of the infectious virus particles were inactivated in the presence of these
chemicals following 24 hr exposure at 4˚C. Given this effect, we decided to freeze PBCV-1 particles at -150˚C without any cryoprotectants. This resulted in ~2.5% recovery of the infectious
virus population, which was stable for storage periods of up to one year (Fig 1). Seeing room
for improvement, we tested the cryo-potential of PBCV-1 in an infected, cell-associated state.
The PBCV-1 replication cycle requires about 6–8 h to release nascent virus particles [34].
Post-infection sampling times for cryopreservation (10, 30, 60, 120, 180, 240, 300, 360 min PI)
followed similar sampling strategies used in PBCV-1 transcription studies [22, 23]. Specifically,
these time points were collected across distinct physiological phases in the PBCV-1 lifecycle
and thus represent likely unique conditions for cryopreservation. Following 24-h storage of
cryopreserved, infected cells, we found that late stages of infection were more conducive to
virus survival than early stages (Fig 2). Thus, we followed cryo-stability for one year in one
early (10 min PI) and two late infection stages (180 and 240 min PI) (Fig 3). Small day-to-day
fluctuations in virus titers were common, but were typically consistent among treatments, suggesting human error. Despite these fluctuations, the virus particle stock control, 180-min, and
240-min PI treatment yielded an acceptable relative standard deviation (RSD) for these plate
counts [35] across all recovery assessments, indicating cryo-stability (Table 1). Cryo-stability

Fig 1. Cryo-stability of the PBCV-1 particle. Viability of chlorovirus PBCV-1 was determined by plaque assaying viruses that had
been stored as particles either at 4˚C or -150˚C. Green circles represent virus particles stored at 4˚C, while red squares denote virus
particles stored at -150˚C. Error bars are represented as the standard deviation of biological and technical replicates.
https://doi.org/10.1371/journal.pone.0211755.g001
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Fig 2. Recovery of infectious PBCV-1 frozen at various times after PBCV-1 infection of the C. variabilis NC64A host. Viability
of chlorovirus PBCV-1 was assayed by monitoring plaque formation of cell-associated viruses that were collected at different times
during an active infection cycle of the NC64A host. Open circles denote replicate plaque titers, with the average represented by the
solid line.
https://doi.org/10.1371/journal.pone.0211755.g002

was not observed in the 10 min PI samples (Table 1). In comparison to virus particle cryopreservation, the cell-associated method yielded significant improvement in survivorship for the
optimal 240-minute treatment (24.9–30.1 fold increases).

Discussion
The current maintenance strategy for chloroviruses involves serial propagation on the alga
host followed by lysate particle storage at 4˚C. Chloroviruses are relatively stable under these
conditions, though even PBCV-1 is known to degrade after several years of storage. In any
case, many algae-virus systems are less amenable to long-term storage at 4˚C. For example,
new algae-virus systems are not always quickly made axenic, and are thus susceptible to degradation from contaminating bacteria. On the other hand, viruses propagated on axenic hosts
can still degrade. For reasons unknown, chloroviruses are more stable in lysates (bacterialfree) than in particle stocks purified by sucrose density gradients [36], but they always eventually lose their infectivity. Serial propagation of viruses is therefore often required. Even if this is
done infrequently, it can still promote genetic drift and result in deviation from wild-type status. This is concerning for all virus types, though RNA viruses, which have the fastest mutation
rates, would be most susceptible [9, 37]. Beyond considering spontaneous, replication-associated errors, chloroviruses encode putative enzymes involved in genomic rearrangements. For
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Fig 3. Long-term cryo-stability of PBCV-1 frozen in host cells at various times after infection of its host C. variabilis NC64A.
Infectious chlorovirus PBCV-1 was monitored by plaque assay in virus particle stocks stored at 4˚C (green circles) and in
cryopreserved, PBCV-1-infected host cultures. Blue triangles, yellow squares, and orange diamonds represent virus viability
following storage of infected cells cryopreserved after 240, 180, and 10 minutes PI. Error bars represent the standard deviation
among biological and technical replicates.
https://doi.org/10.1371/journal.pone.0211755.g003

example, GIY-YIG mobile endonucleases and an IS607 transposon may be involved in insertions/deletions and/or gene loss/duplications observed in genomic comparisons of chloroviruses [38, 39]. Thus, maintenance of wild-type strains is important for consistency between
experiments. Virology labs could follow the microbial culture collection strategy, which typically uses a cryo-banking/seed-stock system for the dissemination of microbial specimens. The
purpose of the seed-stock system is to minimize serial propagation of microbiota. The American Type Culture Collection (ATCC) suggests that consumers transfer their cultures no more
than five-times after propagation from the thawed culture collection stock. Though a
Table 1. Statistical assessment of PBCV-1 infectivity across storage treatments for ~1 year.
Treatment

N

Virus Particle Stock (4˚C)

67

Average

SD

Virus Particle Stock (-150˚C)

124

2.53

Cell-associated virus 10 minutes PI (-150˚C, +CPA)

79

7.56

75.1

RSD

95%CI
22.5�

71.1–79.2

0.61

24.0�

2.42–2.64

3.38

44.7

6.81–8.31

16.9

�

Cell-associated virus 180 minutes PI (-150˚C, +CPA)

82

31.9

10.9

34.2

29.5–34.3

Cell-associated virus 240 minutes PI (-150˚C, +CPA)

82

69.5

16.5

23.8�

65.9–73.0

+CPA, cryoprotectants present as described in materials and methods section. Asterisks (� ) denote an acceptable RSD (i.e., Coefficient of Variation) for plaque assays
based on a 35% threshold used in bacterial plating standards set from chapter 1223 by the U.S. Pharmacopeia and National Formulary.
https://doi.org/10.1371/journal.pone.0211755.t001
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seemingly strict standard, it is not difficult to imagine the consequences of violating this. For
example, the United States Pharmacopeia and National Formulary requires test organisms to
be maintained this way for routine antibiotic efficacy screens, and non-compliance can undermine therapeutic treatment [35]. Although there is no direct clinical link to maintaining algal
viruses this way, the logic is consistent with any research requirements. The cryopreservation
protocol described here can help researchers better set up these cryo-banking/seed stock
systems.
Standard cryopreservation techniques are not designed for the unique structure and physiology of virus particles. Indeed, cryoprotectants are classified by their permeability across cell
membranes, which often coincides with their molecular weight [24]. Smaller compounds,
such as ethylene glycol and DMSO, are considered penetrating cryoprotectants, while larger
compounds (e.g. amino acids; L-proline) are typically non-penetrating. That said, the exclusion size threshold has not been established for most viruses so it is not clear which, if any of
these compounds penetrate the viral capsid. It is generally thought that virus capsids are permeable to water and ions, though the latter diffuses much slower; this mechanism has been
used to osmotically rupture capsids [40, 41], including PBCV-1 [42]. The final cryoprotectant
solution used for PBCV-1 particle cryopreservation has an estimated osmolarity of ~150 mOsmoles/L, which is comparable to the storage buffer used for this virus. In light of this, we propose that the lethal effect the cryoprotectants have on the PBCV-1 particle is not the result of
osmotic stress, and that inactivation instead occurred by toxicity of cryoprotectants or oxidative stress. This would be consistent with viruses not being metabolically active and therefore
unable to repair damage caused by this treatment. It is also consistent with the observation
that Mimivirus, a giant virus relative which also contains an internal lipid membrane, is said to
be inactivated by lipophilic compounds such as DMSO [43]. That said, DMSO is often used as
a stabilizer for freezing of enveloped virus particles [44]. This discrepancy may be due to
unique properties between external and internal membranes, or even system differences
between animal and plant viruses, which imparts resistance in some cases over others. Regardless, the mechanism of inactivation may be better ascertained by looking at survivorship of
virion particles via epifluorescent microscopy, flow cytometry [45–47], or using bioassays to
quantify oxidative stress.
Although the algal cell is in a sub-optimal physiological state during infection, it is apparently robust enough to survive and maintain an active infection during cryopreservation. That
said, fewer infectious virus were recovered when the cell was cryopreserved during early infection stages. This might be explained by differences in adsorption rates and synchronicity of
infection, resulting in fewer infected cells at the start of the experiment. Most, if not all cells are
infected at the later stages of infection (3–4 hr PI). Regardless of any differences in synchronicity, the algal cell will be completely arrested during cryopreservation, and will only continue
the infection cycle after thawing. Internal, mature viruses that have not yet lysed their host cell
might still be inactivated by cryoprotectants, thus reducing viral burst size, but our experiments did not account for this. We also did not account for inefficiencies in infection rates;
though we infected at M.O.I. values based on infectious particle counts, it is possible that all
the cells were not infected. Had we plated the infected cell population prior to cryoprotection
we could have corrected for this in our results. In any case, accounting for infection inefficiency can only improve PBCV-1 survivorship and the success of our method.
The general classification of cryoprotectants based on membrane permeability is consistent
in the infected cell treatment. Although the C. variabilis NC64A genome encodes a secondary
active transporter for the uptake of proline, radio-labeled solute uptake experiments revealed
that PBCV-1 infection abolishes its activity [48]. With that in mind, the tonicity of the cryoprotectant mixture would equate to ~90 mOsmoles/L, as only DMSO and ethylene glycol are
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penetrating, and many of the components in the MBBM media would be spent by late-logarithmic growth. This concentration is comparable to buffers routinely used in our lab for handling C. variabilis (40 mOsmoles/L), so there is little concern of osmotic stress. The chances
of osmotic stress were also low considering the consistent success associated with this cryopreservation formula across eukaryotic algae, including two Chlorella spp. [29]. Our results are
likely applicable to any algal virus whose host can be cryopreserved. That said, we expect that
researchers may still have to adjust their cryoprotectant mixture to account for system differences related to osmolarity tolerance and cryoprotectant toxicity. There has also been research
indicating that axenicity impacts cryopreservation survival in microalgae. In this light, it is
possible that the bacterial community produces secondary metabolites which promote survival
[49]. In another scenario, organisms with psychrophilic tendencies might be adapted to freeze
situations and cryoprotectant additives may not be necessary.
The goal of this study was to develop a long-term cryopreservation method for chlorovirus
PBCV-1, but there are also interesting ecological implications of this research. Recent metagenomic and isolation efforts indicate that giant viruses of microeukaryotes (e.g., Phycodnaviridae and Mimiviridae) are widely distributed in nature [50, 51], but it is not well understood
how these viruses persist in the environment. Freezing events represent a potential mechanism
of inactivation for some algal viruses, though chlorovirus ATCV-1 is stable during these conditions [19]. In two other studies, a closely related giant virus of the family Mimiviridae [52], as
well as a second giant virus in the family Molliviridae [53], were revived from 30,000 year old
permafrost. Both of these viruses were revived using Acanthamoeba spp., one of the main hosts
for many giant viruses. That said, there have been questions about whether Acanathamoeba
and other protists used for laboratory viral propagation are the natural or primary hosts of
these ancient viruses [54]. Although these viruses might be able to withstand freezing temperatures on their own, the results of this study suggest that a natural host might serve as a better
vehicle for surviving freezing. Indeed, many microbes produce natural cryoprotectants (e.g. Lproline, trehalose, betatine, etc.) or encode machinery to transport these osmoprotectants into
the cell. Following this thought process, it is possible that environments containing frozen,
infected cells might contain naturally cryopreserved algal-virus systems. These systems may be
deciphered following advances in single-cell sorting and sequencing techniques. Indeed, a similar approach has been successfully utilized to identify and sequence single virus genomes in
the ocean [55]. Though this latter study sorted virus particles, flow-cytometry sorting of viral
infected cells may be achieved using fluorescent probes specific for viral marker genes (e.g.,
major capsid protein) or dyes to detect viral-induced host phenotypes (e.g., membrane blebbing). As a proof of concept, viral genetic sequences recovered from Siberian permafrost could
be used to probe for still frozen viral-infected host cells, thereby testing the natural host range
of these viruses.
To our knowledge, this is the first report of successful cryopreservation of a eukaryotic algal
virus during its infection cycle. We expect that respective cellular hosts will provide more suitable physiological conditions for cryopreservation and storage of algal viruses that infect
eukaryotic algae. We also recommend that laboratories working with algal viruses establish
cryopreserved seed-stock systems to better preserve wild-type controls for future experimentation, especially in lieu of future modification of these viral systems.
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